§01 — Browse · Compounds Database
Browse compounds.
— / 79 records
§01.01
Anabolic
27 compounds
| # | Compound | Route | Typical Dose | T½ · Decay | Risk | Profile |
|---|---|---|---|---|---|---|
| 01 |
Testosterone
Test
|
INJ | 500.0mg/wk |
~7d
|
▮▮▯▯▯ MILD |
Injectable
Aromatizer
Mass builder
Beginner-friendly
Test base
|
| 02 |
Masteron
Drostanolone
|
INJ | 400.0mg/wk |
~2d
|
▮▯▯▯▯ LOW |
Injectable
DHT derivative
Cutting
Anti-estrogen
Hardening
|
| 03 |
Anavar
Oxandrolone
|
ORAL | 50.0mg/d |
8h
|
▮▯▯▯▯ LOW |
Oral
DHT derivative
Cutting
Beginner-friendly
Mild
Lipo-toxic
|
| 04 |
Dianabol
Metandienone
|
ORAL | 30.0mg/d |
6h
|
▮▮▮▮▯ HIGH |
Oral
Aromatizer
Mass builder
Hepatotoxic
Water retention
C17-AA
|
| 05 |
Anadrol
Oxymetholone
|
ORAL | 50.0mg/d |
8h
|
▮▮▮▮▮ EXTREME |
Oral
DHT derivative
Mass builder
Advanced only
Hepatotoxic
Estrogenic effects
Polycythemic
C17-AA
|
| 06 |
Turinabol
Tbol
|
ORAL | 50.0mg/d |
16h
|
▮▮▮▯▯ MOD |
Oral
Beginner-friendly
Hepatotoxic
Mild
Lean gains
C17-AA
|
| 07 |
Halotestin
Halo
|
ORAL | 20.0mg/d |
6h
|
▮▮▮▮▮ EXTREME |
Oral
DHT derivative
Cutting
Advanced only
Hepatotoxic
Neurotoxic
C17-AA
Ultra-hepatotoxic
|
| 08 |
Trestolone
MENT
|
INJ | 175.0mg/wk |
~1d
|
▮▮▮▮▮ EXTREME |
Injectable
19-nor
Advanced only
Progestin
Extreme aromatizer
Strong prolactin
Extreme potency
|
| 09 |
Superdrol
Methasterone
|
ORAL | 20.0mg/d |
8h
|
▮▮▮▮▮ EXTREME |
Oral
DHT derivative
Advanced only
Hepatotoxic
Extreme potency
Ultra-hepatotoxic
|
| 10 |
Epistane
Methylepitiostanol
|
ORAL | 30.0mg/d |
6h
|
▮▮▮▯▯ MOD |
Oral
DHT derivative
Cutting
Beginner-friendly
Hepatotoxic
Anti-estrogen
|
| 11 |
1-Testosterone
DHB
|
INJ | 400.0mg/wk |
~7d
|
▮▮▮▮▯ HIGH |
Injectable
DHT derivative
Cutting
Advanced only
Lean gains
Hardening
|
| 12 |
Mibolerone
Cheque Drops
|
ORAL | 5.0mg/d |
4h
|
▮▮▮▮▮ EXTREME |
Oral
DHT derivative
Advanced only
Extreme potency
Neurotoxic
C17-AA
Ultra-hepatotoxic
Hair unsafe
|
| 13 |
M-Tren
Methyltrienolone
|
ORAL | 0.5mg/d |
6h
|
▮▮▮▮▮ EXTREME |
Oral
Cutting
Advanced only
Progestin
Strong prolactin
Extreme potency
HPTA-killer
C17-AA
Ultra-hepatotoxic
Nephrotoxic
|
| 14 |
4-Androstenediol
4-AD
|
ORAL | 300.0mg/d |
6h
|
▮▮▮▯▯ MOD |
Oral
Aromatizer
Beginner-friendly
Hepatotoxic
Mild
|
| 15 |
LGD-4033
Ligandrol
|
ORAL | 10.0mg/d |
~1d
|
▮▮▮▯▯ MOD |
Oral
Beginner-friendly
Hepatotoxic
Mild
Lean gains
|
| 16 |
Ostarine
MK-2866
|
ORAL | 20.0mg/d |
~1d
|
▮▯▯▯▯ LOW |
Oral
Beginner-friendly
Mild
Lean gains
|
| 17 |
RAD-140
Testolone
|
ORAL | 20.0mg/d |
16h
|
▮▯▯▯▯ LOW |
Oral
|
| 18 |
Andarine
S-4
|
ORAL | 50.0mg/d |
4h
|
▮▯▯▯▯ LOW |
Oral
Cutting
|
| 19 |
S-23
S-23
|
ORAL | 20.0mg/d |
12h
|
▮▮▮▮▮ EXTREME |
Oral
Advanced only
|
| 20 |
YK-11
YK11
|
ORAL | 10.0mg/d |
6h
|
▮▮▮▮▮ EXTREME |
Oral
Advanced only
|
| 21 |
LGD-3303
LGD-3303
|
ORAL | 10.0mg/d |
6h
|
▮▯▯▯▯ LOW |
Oral
|
| 22 |
ACP-105
ACP-105
|
ORAL | 10.0mg/d |
8h
|
▮▯▯▯▯ LOW |
Oral
Mild
|
| 23 |
Trenbolone
Tren
|
INJ | 350.0mg/wk |
~1d
|
▮▮▮▮▯ HIGH |
Injectable
19-nor
Cutting
Advanced only
Progestin
Strong prolactin
Neurotoxic
Nephrotoxic
|
| 24 |
Nandrolone
Deca
|
INJ | 400.0mg/wk |
~3d
|
▮▮▮▯▯ MOD |
Injectable
Aromatizer
19-nor
Mass builder
Beginner-friendly
Progestin
Joint health
Strong prolactin
|
| 25 |
Equipoise
Boldenone
|
INJ | 600.0mg/wk |
~2.0wk
|
▮▮▯▯▯ MILD |
Injectable
Aromatizer
Mass builder
Beginner-friendly
Anti-estrogen
Long ester
Appetite
Polycythemic
Lab-interference
|
| 26 |
Winstrol
Stanozolol
|
ORAL | 50.0mg/d |
8h
|
▮▮▮▯▯ MOD |
Oral
DHT derivative
Cutting
Hepatotoxic
Joint stress
Hardening
Lipo-toxic
Collagen-inhibitor
C17-AA
|
| 27 |
Primo
Primobolan
|
INJ | 600.0mg/wk |
~7d
|
▮▯▯▯▯ LOW |
Injectable
DHT derivative
Cutting
Beginner-friendly
Mild
Expensive
Lean gains
|
§01.03
Metabolic
5 compounds
| # | Compound | Route | Typical Dose | T½ · Decay | Risk | Profile |
|---|---|---|---|---|---|---|
| 01 |
Cardarine
GW501516
|
ORAL | 15.0mg/d |
16h
|
▮▯▯▯▯ LOW |
Oral
Cutting
Non-suppressive
Fat loss
|
| 02 |
SR9009
Stenabolic
|
ORAL | 20.0mg/d |
4h
|
▮▯▯▯▯ LOW |
Injectable
Oral
Cutting
Non-suppressive
Fat loss
|
| 03 |
MK-677
Ibutamoren
|
ORAL | 25.0mg/d |
~1d
|
▮▯▯▯▯ LOW |
Oral
Non-suppressive
|
| 04 |
Yohimbine
Yohimbine HCl
|
ORAL | 10.0mg/d |
1.0h
|
▮▯▯▯▯ LOW |
Oral
Cutting
Fat loss
Stimulant
Alpha-2 antagonist
|
| 05 |
Clenbuterol
Clen
|
ORAL | 40.0mg/d |
~1d
|
▮▯▯▯▯ LOW |
Oral
Cutting
Non-suppressive
Fat loss
Stimulant
Beta-agonist
|
§01.04
Ancillary
22 compounds
| # | Compound | Route | Typical Dose | T½ · Decay | Risk | Profile |
|---|---|---|---|---|---|---|
| 01 |
Clomid
Androxal
|
ORAL | 25.0mg/d |
~5d
|
▮▮▯▯▯ MILD |
Oral
Ancillary
SERM
PCT
|
| 02 |
Ashwagandha
Withania somnifera
|
ORAL | 600.0mg/d |
12h
|
▮▯▯▯▯ LOW |
Oral
Ancillary
|
| 03 |
Glycine
Glycine supplement
|
ORAL | 2000.0mg/d |
4h
|
▮▯▯▯▯ LOW |
Oral
Ancillary
|
| 04 |
Mesterolone
Proviron
|
ORAL | 50.0mg/d |
12h
|
▮▯▯▯▯ LOW |
Oral
DHT derivative
Anti-estrogen
Libido
Ancillary
SHBG-suppressive
|
| 05 |
Astragalus
Astragalus membranaceus
|
ORAL | 1000.0mg/d |
12h
|
▮▯▯▯▯ LOW |
Oral
Ancillary
|
| 06 |
Tamoxifen
Nolvadex
|
ORAL | 20.0mg/d |
~7d
|
▮▯▯▯▯ LOW |
Oral
Ancillary
|
| 07 |
Clomiphene
Clomid
|
ORAL | 50.0mg/d |
~5d
|
▮▯▯▯▯ LOW |
Oral
Ancillary
|
| 08 |
Arimidex
Anastrozole
|
ORAL | 0.5mg/d |
~2d
|
▮▯▯▯▯ LOW |
Oral
Ancillary
AI
|
| 09 |
Aromasin
Exemestane
|
ORAL | 12.5mg/d |
~1d
|
▮▯▯▯▯ LOW |
Oral
Ancillary
AI
|
| 10 |
Cabergoline
Caber
|
INJ | 0.5mg/wk |
~7d
|
▮▯▯▯▯ LOW |
Ancillary
|
| 11 |
Letrozole
Femara
|
ORAL | 1.25mg/d |
~2d
|
▮▯▯▯▯ LOW |
Oral
Ancillary
AI
|
| 12 |
Dutasteride
Avodart
|
ORAL | 0.5mg/d |
~7.1wk
|
▮▯▯▯▯ LOW |
Oral
Ancillary
|
| 13 |
TUDCA
Tauroursodeoxycholic Acid
|
ORAL | 500.0mg/d |
~1d
|
▮▯▯▯▯ LOW |
Oral
Ancillary
|
| 14 |
Glucosamine
Glucosamine Sulfate
|
ORAL | 1500.0mg/d |
~1d
|
▮▯▯▯▯ LOW |
Oral
Ancillary
|
| 15 |
HCG
Human Chorionic Gonadotropin
|
INJ | 500.0mg/wk |
~1d
|
▮▯▯▯▯ LOW |
Injectable
Ancillary
|
| 16 |
NAD+
Nicotinamide Adenine Dinucleotide
|
ORAL | 500.0mg/d |
0.5h
|
▮▯▯▯▯ LOW |
Injectable
Oral
Recovery
|
| 17 |
ITPP
Myo-Inositol Trispyrophosphate
|
INJ | 1000.0mg/wk |
12h
|
▮▯▯▯▯ LOW |
Injectable
|
| 18 |
Omega-3 EPA/DHA
Fish Oil
|
ORAL | 4000.0mg/d |
~1d
|
▮▯▯▯▯ LOW |
Oral
Ancillary
|
| 19 |
UDCA
Ursodeoxycholic Acid
|
ORAL | 500.0mg/d |
~1d
|
▮▯▯▯▯ LOW |
Oral
Ancillary
|
| 20 |
Citrus Bergamot
Bergamot Extract
|
ORAL | 1000.0mg/d |
12h
|
▮▯▯▯▯ LOW |
Oral
Ancillary
|
| 21 |
Finasteride
Propecia
|
ORAL | 1.0mg/d |
~1d
|
▮▯▯▯▯ LOW |
Oral
Ancillary
|
| 22 |
HMG
Human Menopausal Gonadotropin
|
INJ | 75.0mg/wk |
~1d
|
▮▯▯▯▯ LOW |
Injectable
Ancillary
|
§01.05
Peptide
25 compounds
| # | Compound | Route | Typical Dose | T½ · Decay | Risk | Profile |
|---|---|---|---|---|---|---|
| 01 |
Tesamorelin
Egrifta
|
INJ | 2.0mg/wk |
0.5h
|
▮▮▯▯▯ MILD |
Injectable
Peptide
Growth hormone
Fat loss
|
| 02 |
Humalog Insulin
Insulin Lispro
|
INJ | 8.0mg/wk |
1.0h
|
▮▮▮▮▮ EXTREME |
Injectable
Advanced only
|
| 03 |
IGF-1 LR3
Long-R3 IGF-1
|
INJ | 50.0mg/wk |
20h
|
▮▮▯▯▯ MILD |
Injectable
Cutting
Recovery
|
| 04 |
Lantus Insulin
Insulin Glargine
|
INJ | 6.0mg/wk |
~1d
|
▮▮▮▮▮ EXTREME |
Injectable
Advanced only
|
| 05 |
Humulin R
Regular Human Insulin
|
INJ | 6.0mg/wk |
4h
|
▮▮▮▮▮ EXTREME |
Injectable
Advanced only
|
| 06 |
CJC-1295
CJC-1295 DAC
|
INJ | 2000.0mg/wk |
~7d
|
▮▮▯▯▯ MILD |
Injectable
Peptide
Growth hormone
Recovery
|
| 07 |
Ipamorelin
IPA
|
INJ | 200.0mg/wk |
2h
|
▮▮▯▯▯ MILD |
Injectable
Mild
No water retention
Peptide
Growth hormone
Recovery
|
| 08 |
BPC-157
Body Protection Compound
|
INJ | 500.0mg/wk |
4h
|
▮▮▯▯▯ MILD |
Injectable
Peptide
Recovery
|
| 09 |
TB-500
Thymosin Beta-4
|
INJ | 5000.0mg/wk |
~7d
|
▮▮▯▯▯ MILD |
Injectable
Peptide
Recovery
|
| 10 |
HGH Fragment 176-191
HGH Frag
|
INJ | 400.0mg/wk |
0.5h
|
▮▮▯▯▯ MILD |
Injectable
Cutting
Peptide
Fat loss
|
| 11 |
Semaglutide
Ozempic
|
INJ | 1000.0mg/wk |
~7d
|
▮▮▯▯▯ MILD |
Injectable
Cutting
Peptide
|
| 12 |
Tirzepatide
Mounjaro
|
INJ | 7500.0mg/wk |
~5d
|
▮▮▯▯▯ MILD |
Injectable
Cutting
Peptide
|
| 13 |
Melanotan II
MT-II
|
INJ | 500.0mg/wk |
~1d
|
▮▮▯▯▯ MILD |
Injectable
Cutting
Peptide
|
| 14 |
IGF-1 DES
Des(1-3)IGF-1
|
INJ | 60.0mg/wk |
0.2h
|
▮▮▯▯▯ MILD |
Injectable
Recovery
|
| 15 |
MGF
Mechano Growth Factor
|
INJ | 200.0mg/wk |
~3d
|
▮▮▯▯▯ MILD |
Injectable
Recovery
|
| 16 |
GHRP-6
Growth Hormone Releasing Peptide-6
|
INJ | 150.0mg/wk |
0.5h
|
▮▮▯▯▯ MILD |
Injectable
Peptide
Growth hormone
Recovery
|
| 17 |
Hexarelin
Examorelin
|
INJ | 150.0mg/wk |
0.5h
|
▮▮▯▯▯ MILD |
Injectable
Peptide
Growth hormone
Recovery
|
| 18 |
PT-141
Bremelanotide
|
INJ | 1000.0mg/wk |
2h
|
▮▮▯▯▯ MILD |
Injectable
Libido
Peptide
|
| 19 |
PE-22-28
Spadin analogue
|
INJ | 200.0mg/wk |
2h
|
▮▮▯▯▯ MILD |
Injectable
Peptide
|
| 20 |
FOXO4-DRI
FOXO4 D-retro-inverso peptide
|
INJ | 2.0mg/wk |
12h
|
▮▮▯▯▯ MILD |
Injectable
Peptide
|
| 21 |
Novolog Insulin
Insulin Aspart
|
INJ | 8.0mg/wk |
1.0h
|
▮▮▮▮▮ EXTREME |
Injectable
Advanced only
|
| 22 |
GHRP-2
Growth Hormone Releasing Peptide-2
|
INJ | 150.0mg/wk |
0.5h
|
▮▮▯▯▯ MILD |
Injectable
Peptide
Growth hormone
Recovery
|
| 23 |
Retatrutide
GLP-1/GIP/glucagon triple agonist
|
INJ | 4.0mg/wk |
~7d
|
▮▮▯▯▯ MILD |
Injectable
Cutting
Peptide
|
| 24 |
hGH
Human Growth Hormone
|
INJ | 4.0mg/wk |
4h
|
▮▮▯▯▯ MILD |
Injectable
Cutting
Growth hormone
Recovery
Fat loss
|
| 25 |
MOTS-c
Mitochondrial ORF of the 12S rRNA type-c
|
INJ | 10.0mg/wk |
4h
|
▮▮▯▯▯ MILD |
Injectable
Peptide
|